Vaš brskalnik ne omogoča JavaScript!
JavaScript je nujen za pravilno delovanje teh spletnih strani. Omogočite JavaScript ali pa uporabite sodobnejši brskalnik.
Nacionalni portal odprte znanosti
Odprta znanost
DiKUL
slv
|
eng
Iskanje
Brskanje
Novo v RUL
Kaj je RUL
V številkah
Pomoč
Prijava
The contemporary approach to CALR-positive myeloproliferative neoplasms
ID
Belčič, Tanja
(
Avtor
),
ID
Pajič, Tadej
(
Avtor
),
ID
Zver, Samo
(
Avtor
),
ID
Sever, Matjaž
(
Avtor
)
PDF - Predstavitvena datoteka,
prenos
(4,08 MB)
MD5: 790D62E9CA1DD622674F2B0EE3E1E272
URL - Izvorni URL, za dostop obiščite
https://www.mdpi.com/1422-0067/22/7/3371
Galerija slik
Izvleček
CALR mutations are a revolutionary discovery and represent an important hallmark of myeloproliferative neoplasms (MPN), especially essential thrombocythemia and primary myelofibrosis. To date, several CALR mutations were identified, with only frameshift mutations linked to the diseased phenotype. It is of diagnostic and prognostic importance to properly define the type of CALR mutation and subclassify it according to its structural similarities to the classical mutations, a 52-bp deletion (type 1 mutation) and a 5-bp insertion (type 2 mutation), using a statistical approximation algorithm (AGADIR). Today, the knowledge on the pathogenesis of CALR-positive MPN is expanding and several cellular mechanisms have been recognized that finally cause a clonal hematopoietic expansion. In this review, we discuss the current basis of the cellular effects of CALR mutants and the understanding of its implementation in the current diagnostic laboratorial and medical practice. Different methods of CALR detection are explained and a diagnostic algorithm is shown that aids in the approach to CALR-positive MPN. Finally, contemporary methods joining artificial intelligence in accordance with molecular-genetic biomarkers in the approach to MPN are presented.
Jezik:
Angleški jezik
Ključne besede:
calreticulin
,
chaperone
,
calcium
,
myeloproliferative neoplasm
,
diagnostics
,
thrombocythemia
,
artificial intelligence
Vrsta gradiva:
Članek v reviji
Tipologija:
1.02 - Pregledni znanstveni članek
Organizacija:
MF - Medicinska fakulteta
Status publikacije:
Objavljeno
Različica publikacije:
Objavljena publikacija
Leto izida:
2021
Št. strani:
16 str.
Številčenje:
Vol. 22, iss. 7, art. 3371
PID:
20.500.12556/RUL-135222
UDK:
616.1
ISSN pri članku:
1422-0067
DOI:
10.3390/ijms22073371
COBISS.SI-ID:
57640451
Datum objave v RUL:
01.03.2022
Število ogledov:
820
Število prenosov:
141
Metapodatki:
Citiraj gradivo
Navadno besedilo
BibTeX
EndNote XML
EndNote/Refer
RIS
ABNT
ACM Ref
AMA
APA
Chicago 17th Author-Date
Harvard
IEEE
ISO 690
MLA
Vancouver
:
Kopiraj citat
Objavi na:
Gradivo je del revije
Naslov:
International journal of molecular sciences
Skrajšan naslov:
Int. j. mol. sci.
Založnik:
MDPI
ISSN:
1422-0067
COBISS.SI-ID:
2779162
Licence
Licenca:
CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:
http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:
To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.
Začetek licenciranja:
01.04.2021
Sekundarni jezik
Jezik:
Slovenski jezik
Ključne besede:
kalcij
,
mieloproliferativne neoplazme
,
diagnostika
,
trombocitemija
,
umetna inteligenca
Projekti
Financer:
Drugi - Drug financer ali več financerjev
Program financ.:
Department of Hematology
Financer:
Drugi - Drug financer ali več financerjev
Program financ.:
Clinical Institute for Genomic Medicine
Podobna dela
Podobna dela v RUL:
Podobna dela v drugih slovenskih zbirkah:
Nazaj